Insider · CIK 0001897585
Kyle Dempsey
Files at OPTN (OptiNose, Inc.). First filing -, latest -.
Kyle Dempsey files SEC Form 4 as director at OPTN (OptiNose, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kyle Dempsey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,566 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,133 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,925 | - | - | 0 | May 21, 2025 |
Questions about Kyle Dempsey
Answered from the filings on this page, as of the latest one.
Is Kyle Dempsey buying or selling?
Kyle Dempsey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kyle Dempsey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kyle Dempsey has 0.
Where does Kyle Dempsey file Form 4?
Kyle Dempsey has filed Form 4 at OPTN (OptiNose, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.